{{item.title}}
{{item.text}}
9 successful US FDA inspections
2013-2021
4 successful EU EMA inspections
2019-2022
30+ successful China NMPA inspections
2015-2022
4 successful Japan EMA inspections
2019-2022
4 successful South Korean MFDS inspections
2022
3 successful SwissMedic inspections
2018-2020
300+ client audits every year
1st CDMO to support a new drug launch in China via ONE integrated CMC platform including both drug substance and drug product
105 country approvals for branded drugs
210+ CMC submission packages written to support global IND and NDA filings since 2019
{{item.text}}